Chitosan supplementation and Coronavirus

Phase 2

• Conditions: COVID-19 infection.; COVID-19; virus identified; U07.1

• Registration Number: IRCT20210510051243N1
• Lead Sponsor: Arak University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 8 March 2022

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Age between 20 to 75 years,
Willingness to participate with written informed consent,
Diagnosis of coronavirus based on the PCR test.

Exclusion Criteria

Current use of warfarin,
Presence of sensitivity to seafood.

Study & Design

• Study Type: interventional
• Study Design: Not specified